Mathieu Uzzan (@mat_uzz) 's Twitter Profile
Mathieu Uzzan

@mat_uzz

Physician-scientist #IBD #immunology #MondorMICI

ID: 45644606

linkhttps://www.linkedin.com/company/mondor-mici/mycompany/?viewAsMember=true calendar_today08-06-2009 19:19:06

536 Tweet

273 Takipçi

422 Takip Edilen

Harry Sokol (@h_sokol) 's Twitter Profile Photo

Message important de la #SNFGE sur l’inutilité des tests microbiotes et des test d’allergie alimentaire par mesure des IgG youtu.be/hQEUg02pcq4?si…

GETAID (@pgetaid) 's Twitter Profile Photo

Le Séminaire GETAID-REMIND aura lieu le jeudi 5 décembre et le vendredi 6 décembre 2024 ! 🎉 Les inscriptions sont ouvertes 😃

Le Séminaire GETAID-REMIND aura lieu le jeudi 5 décembre et le vendredi 6 décembre 2024 ! 🎉

Les inscriptions sont ouvertes 😃
GETAID (@pgetaid) 's Twitter Profile Photo

Les inscriptions pour la Masterclass du GETAID sont lancées ! 🥳 Au programme : mises au point, échanges avec les experts, ateliers,... Le programme complet disponible ici : getaid.org/actualites/mas…

Les inscriptions pour la Masterclass du GETAID sont lancées ! 🥳

Au programme : mises au point, échanges avec les experts, ateliers,...

Le programme complet disponible ici : getaid.org/actualites/mas…
Nathan Grellier (@nathangrellier5) 's Twitter Profile Photo

Early ileal resection in Crohn's disease is not associated with severe long-term outcomes: the ERIC study CD patients from Saint-Antoine and Beaujon Hospital comparing Early vs Late resections onlinelibrary.wiley.com/doi/10.1111/ap… roypounder.apt Philippe Seksik Julien Kirchgesner Harry Sokol

Early ileal resection in Crohn's disease is not associated with severe long-term outcomes: the ERIC study

CD patients from Saint-Antoine and Beaujon Hospital comparing Early vs Late resections

onlinelibrary.wiley.com/doi/10.1111/ap…
<a href="/APandT/">roypounder.apt</a>  
<a href="/PSeksik/">Philippe Seksik</a> <a href="/J_Kirchgesner/">Julien Kirchgesner</a> <a href="/h_sokol/">Harry Sokol</a>
GiulianaMagri (@gmagri_immuno) 's Twitter Profile Photo

Please RT 🙏!📢My lab at Universitat de Barcelona is seeking a highly motivated postdoc to lead an exciting new public-private collaborative project (UB, CRG, CSIC, OrikineBio) aimed at testing a potentially game-changing therapy for IBD. If interested, please contact me at [email protected].

Bram Verstockt (@bverstockt) 's Twitter Profile Photo

Very happy this publication officially kicks off the IBD_COLLIBRI consortium. Let’s continu collaborative research to move the needle for the benefit of our patients !

Mathieu Uzzan (@mat_uzz) 's Twitter Profile Photo

Happy to participate to this important and great team effort with incredible European colleagues and patients representatives Y-ECCO !

GiulianaMagri (@gmagri_immuno) 's Twitter Profile Photo

📢Thrilled to share our work on the ontogeny, reactivity, and function of #IgA subclasses in homeostasis and #IBD! Huge thanks to Andrea, all our amazing collaborators, and Journal of Experimental Medicine for their support throughout the extended revision process! It's time to celebrate🥳!

Xavier Lab (@thexavierlab) 's Twitter Profile Photo

1/3 Thrilled to share exciting new work in nature by Toufic Mayassi, Chenhao Li, Åsa Segerstolpe, et al. Spatial profiling of mouse intestine reveals a landscape robust to perturbations in homeostatic drivers & adaptable in a spatially-restricted manner bit.ly/48ZzJKc

Gustave Roussy (@gustaveroussy) 's Twitter Profile Photo

Elles sont médecins, chercheuses et scientifiques à Gustave Roussy. 💬 « J'ai été baignée dans cet univers féminin, avec ces femmes très fortes et très brillantes. » À l'occasion de la Journée internationale des femmes et des filles de science, découvrez le portrait de la Dr

Julien Kirchgesner (@j_kirchgesner) 's Twitter Profile Photo

🌟 The #ECCO topical review on IBD Predictive Models has been published in Journal of Crohn's and Colitis! 🔍 In this review, we 1️⃣ Summarized all current models 2️⃣ Identified relevant methodology 3️⃣ Provided guidance for future models 🙏 Huge thanks to the team! academic.oup.com/ecco-jcc/advan…

🌟 The #ECCO topical review on IBD Predictive Models has been published in <a href="/JCC_IBD/">Journal of Crohn's and Colitis</a>! 
🔍 In this review, we
1️⃣ Summarized all current models 
2️⃣ Identified relevant methodology
3️⃣ Provided guidance for future models
🙏 Huge thanks to the team!
academic.oup.com/ecco-jcc/advan…
Remo Panaccione, MD, FRCPC (@rpanaccione) 's Twitter Profile Photo

What an absolute honour and privilege to host Prof. Harry Sokol Harry Sokol at the University of Calgary as part of the Snyder Institute for Chronic Diseases endowed chair series . A packed auditorium listening to a masterful talk on the gut microbiota and IBD. Harry is trailblazing the field .

What an absolute honour and privilege to host Prof. Harry Sokol <a href="/h_sokol/">Harry Sokol</a> at the University of Calgary as part of the <a href="/SnyderInstitute/">Snyder Institute for Chronic Diseases</a> endowed chair series . A packed auditorium listening to a masterful talk on the gut microbiota and IBD. Harry is trailblazing the field .
Harry Sokol (@h_sokol) 's Twitter Profile Photo

Join us ! Open #Postdoc position in my lab (Paris, France), to work on the Role of the Gut #microbiota in Host Cells Energy Metabolism in Health and #IBD see details here 🔽🔽🔽🔽 euraxess.ec.europa.eu/jobs/361342 please RT

Esteban FV (@efuentesval) 's Twitter Profile Photo

👩‍⚕️👨‍⚕️Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis ▪︎GETAID multi🏥 retrospective study ▪︎N=169 pts ▪︎SFCR at weeks 8-14: upadacitinib (55.2%) 🆚️filgotinib (33.3%)🆚️tofacitinib (50%) ▪︎upa was associated with ⬆️ odds of SFCR compared to Filgo

👩‍⚕️👨‍⚕️Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis
▪︎GETAID multi🏥 retrospective study
▪︎N=169 pts
▪︎SFCR at weeks 8-14: upadacitinib (55.2%) 🆚️filgotinib (33.3%)🆚️tofacitinib (50%)
▪︎upa was associated with ⬆️ odds of SFCR compared to Filgo